The drug, and another new drug for Alzheimer’s called lecanemab, have been billed as a huge step forward in research because ...

The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...

Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...

Leqembi, first FDA-approved Alzheimer's drug, faces EMA rejection, but shares could potentially surge soon. See why I rate ...

Earlier this year Nice decided not to fund the new ‘miracle’ Alzheimer’s drug on the NHS, but who makes that decision?

Alzheimer’s disease is the leading cause of dementia in the UK. It’s a complex, challenging, and devastating condition that causes a gradual decline in a person’s cognition, including memory and ...

On November 28, 1520, Portuguese navigator Ferdinand Magellan reached the Pacific Ocean after passing through the South American strait that now bears his name.

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...

The Alzheimer’s Association is inviting the community to take part in its annual Walk to End Alzheimer’s on Saturday, Nov. 2.